Trial · NCT01227512
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Length of Hospital Stay (LoS) | Tolvaptan 15-60mg/Day | 3.5 | 95% Confidence Interval 3.0 to 4.5 | Days | |
| Length of Hospital Stay (LoS) | Placebo | 4.0 | 95% Confidence Interval 3.5 to 5.0 | Days | |
| Change From Baseline to 48 Hour Post Dose in Clinical Global Impression-Severity (CGI-S) of Hyponatremia Symptoms. | Tolvaptan 15-60mg/Day | Baseline | 4.0 | Full Range 2.0 to 6.0 | Units on a scale |
| Change From Baseline to 48 Hour Post Dose in Clinical Global Impression-Severity (CGI-S) of Hyponatremia Symptoms. | Placebo | Baseline | 4.0 | Full Range 3.0 to 6.0 | Units on a scale |
| Change From Baseline to 48 Hour Post Dose in Clinical Global Impression-Severity (CGI-S) of Hyponatremia Symptoms. | Tolvaptan 15-60mg/Day | 48 hours post dose | 2.0 | Full Range 1.0 to 6.0 | Units on a scale |
| Change From Baseline to 48 Hour Post Dose in Clinical Global Impression-Severity (CGI-S) of Hyponatremia Symptoms. | Placebo | 48 hours post dose | 3.0 | Full Range 1.0 to 7.0 | Units on a scale |
| Change From Baseline to 48 Hour Post Dose in Clinical Global Impression-Severity (CGI-S) of Hyponatremia Symptoms. | Tolvaptan 15-60mg/Day | Change from baseline | -1.0 | Full Range -3.0 to 3.0 | Units on a scale |
| Change From Baseline to 48 Hour Post Dose in Clinical Global Impression-Severity (CGI-S) of Hyponatremia Symptoms. | Placebo | Change from baseline | -1.0 | Full Range -3.0 to 3.0 | Units on a scale |
| Change From Baseline to 24 and 72 Hours Post Dose in CGI-S of Hyponatremia Symptoms. | Tolvaptan 15-60mg/Day | Baseline | 4.0 | Full Range 2.0 to 6.0 | Units on a scale |
| Change From Baseline to 24 and 72 Hours Post Dose in CGI-S of Hyponatremia Symptoms. | Placebo | Baseline | 4.0 | Full Range 3.0 to 6.0 | Units on a scale |
| Change From Baseline to 24 and 72 Hours Post Dose in CGI-S of Hyponatremia Symptoms. | Tolvaptan 15-60mg/Day | 24 hours post-dose | 3.0 | Full Range 1.0 to 6.0 | Units on a scale |
| Change From Baseline to 24 and 72 Hours Post Dose in CGI-S of Hyponatremia Symptoms. | Placebo | 24 hours post-dose | 3.0 | Full Range 1.0 to 7.0 | Units on a scale |
| Change From Baseline to 24 and 72 Hours Post Dose in CGI-S of Hyponatremia Symptoms. | Tolvaptan 15-60mg/Day | Change from baseline at 24 hours | -1.0 | Full Range -3.0 to 3.0 | Units on a scale |
| Change From Baseline to 24 and 72 Hours Post Dose in CGI-S of Hyponatremia Symptoms. | Placebo | Change from baseline at 24 hours | -1.0 | Full Range -3.0 to 2.0 | Units on a scale |
| Change From Baseline to 24 and 72 Hours Post Dose in CGI-S of Hyponatremia Symptoms. | Tolvaptan 15-60mg/Day | 72 hours post-dose | 2.0 | Full Range 1.0 to 6.0 | Units on a scale |
| Change From Baseline to 24 and 72 Hours Post Dose in CGI-S of Hyponatremia Symptoms. | Placebo | 72 hours post-dose | 2.0 | Full Range 1.0 to 7.0 | Units on a scale |
| Change From Baseline to 24 and 72 Hours Post Dose in CGI-S of Hyponatremia Symptoms. | Tolvaptan 15-60mg/Day | Change from baseline at 72 hours | -2.0 | Full Range -4.0 to 3.0 | Units on a scale |
| Change From Baseline to 24 and 72 Hours Post Dose in CGI-S of Hyponatremia Symptoms. | Placebo | Change from baseline at 72 hours | -1.0 | Full Range -4.0 to 4.0 | Units on a scale |
| Change From Baseline to 48 Hours Post Dose in Clinical Global Impression - Improvement (CGI-I) Score of Hyponatremia Symptoms. | Tolvaptan 15-60mg/Day | 2.0 | Full Range 1.0 to 7.0 | Units on a scale | |
| Change From Baseline to 48 Hours Post Dose in Clinical Global Impression - Improvement (CGI-I) Score of Hyponatremia Symptoms. | Placebo | 2.0 | Full Range 1.0 to 7.0 | Units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01227512/results